Cargando…

GDNF-Transfected Macrophages Produce Potent Neuroprotective Effects in Parkinson's Disease Mouse Model

The pathobiology of Parkinson's disease (PD) is associated with the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) projecting to the striatum. Currently, there are no treatments that can halt or reverse the course of PD; only palliative therapies, such as replacement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yuling, Haney, Matthew J., Gupta, Richa, Bohnsack, John P., He, Zhijian, Kabanov, Alexander V., Batrakova, Elena V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167552/ https://www.ncbi.nlm.nih.gov/pubmed/25229627 http://dx.doi.org/10.1371/journal.pone.0106867

Ejemplares similares

Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson Disease
por: Zhao, Yuling, et al.
Publicado: (2022)

Extracellular Vesicles Released by Genetically Modified Macrophages Activate Autophagy and Produce Potent Neuroprotection in Mouse Model of Lysosomal Storage Disorder, Batten Disease
por: El-Hage, Nazira, et al.
Publicado: (2023)

Specific Transfection of Inflamed Brain by Macrophages: A New Therapeutic Strategy for Neurodegenerative Diseases
por: Haney, Matthew J., et al.
Publicado: (2013)

Effects of striatal transplantation of cells transfected with GDNF gene without pre- and pro-regions in mouse model of Parkinson’s disease
por: Revishchin, A., et al.
Publicado: (2016)

Data on macrophage mediated muscle transfection upon delivery of naked plasmid DNA with block copolymers
por: Mahajan, Vivek, et al.
Publicado: (2016)

Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
por: Drinkut, Anja, et al.
Publicado: (2016)

Correction to: Ret is essential to mediate GDNF’s neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
por: Drinkut, Anja, et al.
Publicado: (2018)

Pre-α-pro-GDNF and Pre-β-pro-GDNF Isoforms Are Neuroprotective in the 6-hydroxydopamine Rat Model of Parkinson's Disease
por: Penttinen, Anna-Maija, et al.
Publicado: (2018)

Targeted Delivery of siRNA Lipoplexes to Cancer Cells Using Macrophage Transient Horizontal Gene Transfer
por: Wayne, Elizabeth C., et al.
Publicado: (2019)

GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease
por: d’Anglemont de Tassigny, Xavier, et al.
Publicado: (2015)

The Future of GDNF in Parkinson's Disease
por: Manfredsson, Fredric P., et al.
Publicado: (2020)

Stress-Induced Executive Dysfunction in GDNF-Deficient Mice, A Mouse Model of Parkinsonism
por: Buhusi, Mona, et al.
Publicado: (2016)

Genetically modified macrophages accomplish targeted gene delivery to the inflamed brain in transgenic Parkin Q311X(A) mice: importance of administration routes
por: Haney, Matthew J., et al.
Publicado: (2020)

Blueberry juice augments exercise-induced neuroprotection in a Parkinson’s disease model through modulation of GDNF levels
por: Castro, Sandra L., et al.
Publicado: (2022)

Extracellular Vesicles as Drug Carriers for Enzyme Replacement Therapy to Treat CLN2 Batten Disease: Optimization of Drug Administration Routes
por: Haney, Matthew J., et al.
Publicado: (2020)

Non-toxic HSC Transplantation-Based Macrophage/Microglia-Mediated GDNF Delivery for Parkinson’s Disease
por: Chen, Cang, et al.
Publicado: (2019)

Neuroinductive properties of mGDNF depend on the producer, E. Coli or human cells
por: Shamadykova, Dzhirgala V., et al.
Publicado: (2021)

Calcitriol Imparts Neuroprotection In Vitro to Midbrain Dopaminergic Neurons by Upregulating GDNF Expression
por: Orme, Rowan P., et al.
Publicado: (2013)

The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system
por: Kramer, Edgar R.
Publicado: (2015)

Combination therapy using GDNF and cell transplant in Parkinson’s disease
por: Xiao, Bin, et al.
Publicado: (2022)

Characterization of 3'-untranslated region of the mouse GDNF gene
por: Oh-hashi, Kentaro, et al.
Publicado: (2012)

PEG-Free Polyion Complex Nanocarriers for Brain-Derived Neurotrophic Factor
por: Fay, James M., et al.
Publicado: (2022)

SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson’s Disease
por: Espinoza, Stefano, et al.
Publicado: (2020)

A Monoclonal Antibody-GDNF Fusion Protein Is Not Neuroprotective and Is Associated with Proliferative Pancreatic Lesions in Parkinsonian Monkeys
por: Ohshima-Hosoyama, Sachiko, et al.
Publicado: (2012)

Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion
por: Batrakova, E V, et al.
Publicado: (2001)

GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson’s Disease
por: Sun, Shoujia, et al.
Publicado: (2020)

Transgenic GDNF Positively Influences Proliferation, Differentiation, Maturation and Survival of Motor Neurons Produced from Mouse Embryonic Stem Cells
por: Cortés, Daniel, et al.
Publicado: (2016)

Brain ischemia downregulates the neuroprotective GDNF-Ret signaling by a calpain-dependent mechanism in cultured hippocampal neurons
por: Curcio, M, et al.
Publicado: (2015)

Astaxanthin is neuroprotective in an aged mouse model of Parkinson’s disease
por: Grimmig, Beth, et al.
Publicado: (2017)

GDNF and Parkinson’s Disease: Where Next? A Summary from a Recent Workshop
por: Barker, Roger A., et al.
Publicado: (2020)

Low Levels of Adenosine and GDNF Are Potential Risk Factors for Parkinson’s Disease with Sleep Disorders
por: Wang, Li, et al.
Publicado: (2023)

Increased Physiological GDNF Levels Have No Effect on Dopamine Neuron Protection and Restoration in a Proteasome Inhibition Mouse Model of Parkinson’s Disease
por: Olfat, Soophie, et al.
Publicado: (2023)

Acylated but not des‐acyl ghrelin is neuroprotective in an MPTP mouse model of Parkinson's disease
por: Bayliss, Jacqueline A., et al.
Publicado: (2016)

Photoreceptor preservation induced by intravitreal controlled delivery of GDNF and GDNF/melatonin in rhodopsin knockout mice
por: García-Caballero, Cristina, et al.
Publicado: (2018)

Endothelins, peptides with potent vasoactive properties, are produced by human macrophages
Publicado: (1990)

Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson’s Disease
por: Fan, Ching-Hsiang, et al.
Publicado: (2016)

GDNF Receptor Agonist Alleviates Motor Imbalance in Unilateral 6-Hydroxydopamine Model of Parkinson’s Disease
por: Renko, Juho-Matti, et al.
Publicado: (2020)

Blunt dopamine transmission due to decreased GDNF in the PFC evokes cognitive impairment in Parkinson’s disease
por: Tang, Chuan-Xi, et al.
Publicado: (2022)

Neuroprotective Effect of Echinacoside in Subacute Mouse Model of Parkinson's Disease
por: Liang, Yan, et al.
Publicado: (2019)

Leptin-loaded Extracellular Vesicles Treat Sleep-disordered Breathing in Mice with Obesity
por: Freire, Carla, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_neej81rb4tee8cjqkg4crbklcr